Aisling Capital Management LP Talaris Therapeutics, Inc. Transaction History

Aisling Capital Management LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 03, 2022	SELL	$2.3 - $5.03 $1.17 Million - $2.55 Million	-507,923 Reduced 74.37%	175,000 $460,000
Q2 2021 Aug 06, 2021	BUY	$12.25 - $18.61 $8.37 Million - $12.7 Million	682,923 New	682,923 $10 Million

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Aisling Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Aisling Capital Management LP with notifications on news.